Switzerland: What A Mess!

Swiss National Bank intervenes to prevent appreciation of the Franc yet the negative economic fundamentals and weighting of the ETF will outstrip the positives of currency devaluation…

 

Position: Short Switzerland via the etf EWL

 

SNB started buying foreign currencies on March 12th to encourage devaluation of the Franc versus the Euro and Pound and reduced its benchmark interest rate to 0.25% to improve liquidity by lowering borrowing costs.  The SNB is now continuing to devalue the Franc by buying foreign currencies and corporate bonds.

 

On the margin, Swiss monetary policy is positive. A weaker Swiss Franc will benefit exports to its largest trading partner, the Euro zone, and better match deflating prices and waning demand that are pushing down GDP. Since 3/09 the Franc has depreciated 3.7% versus the Euro and Pound.

 

The Swiss Market Index is down -9.7% YTD, but up +6.9% in the last four weeks.  We shorted the Swiss etf EWL on 3/25 at an intermediate top.

 

Yet our negative outlook on the country is confirmed by Switzerland’s fundamentals. Despite the positive “spirit” coming from G20 along with the $1Tillion increase to the IMF’s balance sheet, Western Europe has a ways to go before it recovers from its recession, especially Switzerland, which is levered to European financials.

 

From a monetary standpoint the SNB has run out of room to cut interest rates, and deflationary pressure is a real concern. Swiss CPI declined 0.4% in March Y/Y, the biggest decline since 1959. Economists predicted a drop of 0.1% after a 0.2% gain in February.

 

While deflated prices (led by a y/y drop in oil costs) will benefit consumers in the short term, unemployment is rising and a weaker Franc will put downward pressure on wages and increase the price of imports. Cooling prices may have the opposite intended effect and prolong the recession, especially if consumers pull back spending and increase personal savings or wait for lower prices, a trend we’re seeing throughout Europe. The economy is forecast to contract as much as 3.5% this year and the SNB expects inflation to remain close to zero in 2010 and 2011. This is a bearish forecast for recovery in the intermediate term.

 

See the chart below - the Swiss eft EWL is heavily concentrated in healthcare (36.33%), consumer staples (22.47%), and financials (17.18%), sectors we’re bearish on. Our Healthcare analyst Tom Tobin is decidedly bearish on Swiss healthcare companies (Roche and Novartis each make up 13.5% of the etf) because they sell primary to the Europe, where profit margins are heavily reduced due to fixed pricing. Nestle makes up 20.2% of consumer staples. We’re bearish US Financials and believe European Financials will lag the US’s recovery by at least 3 Months. Again, Switzerland is heavily levered to financials and EWL’s financial composition includes: Credit Suisse 4.9%; UBS 4.4%; and Zurich Financial 4.2%. 

 

The country’s negative fundamentals coupled with the weighting of the etf in underperforming sectors leaves us confident in our bearish thesis despite the intermediate gains that might result from the central bank’s devaluation of the Franc.

 

Matthew Hedrick
Analyst

Switzerland: What A Mess! - swis1

Switzerland: What A Mess! - swis2


7 Tweets Summing Up What You Need to Know About Today's GDP Report

"There's a tremendous opportunity to educate people in our profession on how GDP is stated and projected," Hedgeye CEO Keith McCullough wrote today. Here's everything you need to know about today's GDP report.

read more

Cartoon of the Day: Crash Test Bear

In the past six months, U.S. stock indices are up between +12% and +18%.

read more

GOLD: A Deep Dive on What’s Next with a Top Commodities Strategist

“If you saved in gold over the past 20 to 25 years rather than any currency anywhere in the world, gold has outperformed all these currencies,” says Stefan Wieler, Vice President of Goldmoney in this edition of Real Conversations.

read more

Exact Sciences Up +24% This Week... What's Next? | $EXAS

We remain long Exact Sciences in the Hedgeye Healthcare Position Monitor.

read more

Inside the Atlanta Fed's Flawed GDP Tracker

"The Atlanta Fed’s GDPNowcast model, while useful at amalgamating investor consensus on one singular GDP estimate for any given quarter, is certainly not the end-all-be-all of forecasting U.S. GDP," writes Hedgeye Senior Macro analyst Darius Dale.

read more

Cartoon of the Day: Acrophobia

"Most people who are making a ton of money right now are focused on growth companies seeing accelerations," Hedgeye CEO Keith McCullough wrote in today's Early Look. "That’s what happens in Quad 1."

read more

People's Bank of China Spins China’s Bad-Loan Data

PBoC Deputy Governor Yi says China's non-performing loan problem has “pretty much stabilized." "Yi is spinning. China’s bad-debt problem remains serious," write Benn Steil and Emma Smith, Council on Foreign Relations.

read more

UnderArmour: 'I Am Much More Bearish Than I Was 3 Hours Ago'

“The consumer has a short memory.” Yes, Plank actually said this," writes Hedgeye Retail analyst Brian McGough. "Last time I heard such arrogance was Ron Johnson."

read more

Buffalo Wild Wings: Complacency & Lack of Leadership (by Howard Penney)

"Buffalo Wild Wings has been plagued by complacency and a continued lack of adequate leadership," writes Hedgeye Restaurants analyst Howard Penney.

read more

Todd Jordan on Las Vegas Sands Earnings

"The quarter actually beat lowered expectations. Overall, the mass segment performed well although base mass lagging is a concern," writes Hedgeye Gaming, Lodging & Leisure analyst Todd Jordan on Las Vegas Sands.

read more

An Update on Defense Spending by Lt. Gen Emo Gardner

"Congress' FY17 omnibus appropriation will fully fund the Pentagon's original budget request plus $15B of its $30B supplemental request," writes Hedgeye Potomac Defense Policy analyst Lt. Gen Emerson "Emo" Gardner USMC Ret.

read more

Got Process? Zero Hedge Sells Fear, Not Truth

Fear sells. Always has. Look no further than Zero Hedge.

read more